The Expanding Role of Somatostatin Analogs in the Management of Neuroendocrine Tumors

od Wolin, Edward M.
Wydane 2012

Challenges in the Diagnosis and Management of Well-Differentiated Neuroendocrine Tumors of the Lung (Typical and Atypical Carcinoid): Current Status and Future Considerations

od Wolin, Edward M.
Wydane w Oncologist (2015)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocri...

od Wolin, Edward M., Hu, Ke, Hughes, Gareth, Bouillaud, Emmanuel, Giannone, Vanessa, Resendiz, Karina Hermosillo
Wydane 2013

Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors

od Wolin, Edward M., Manon, Amandine, Chassaing, Christophe, Lewis, Andy, Bertocchi, Laurent, Richard, Joel, Phan, Alexandria T.
Wydane w J Gastrointest Cancer (2016)

Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States

od Wolin, Edward M., Leyden, John, Goldstein, Grace, Kolarova, Teodora, Hollander, Ron, Warner, Richard R.P.
Wydane w Pancreas (2017)

Patient‐Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo‐Controlle...

od Fisher, George A., Wolin, Edward M., Liyanage, Nilani, Pitman Lowenthal, Susan, Mirakhur, Beloo, Pommier, Rodney F., Shaheen, Montaser, Vinik, Aaron
Wydane w Oncologist (2017)

Peptide Receptor Radionuclide Therapy with Lu-177 Octreotate in patients with Somatostatin Receptor Expressing Neuroendocrine Tumors: Six Years Assessment

od Delpassand, Ebrahim S., Hamiditabar, Mohammadali, Ali, Muzammil, Roys, Joseph, Wolin, Edward M., O’Dorisio, Thomas M., Ranganathan, David, Strosberg, Jonathan R.
Wydane w Clin Nucl Med (2017)

Pharmacokinetic study of aldoxorubicin in patients with solid tumors

od Mita, Monica M., Natale, Ronald B., Wolin, Edward M., Laabs, Brenda, Dinh, Hillary, Wieland, Scott, Levitt, Daniel J., Mita, Alain C.
Wydane w Invest New Drugs (2014)

Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors

od Pavel, Marianne E., Phan, Alexandria T., Wolin, Edward M., Mirakhur, Beloo, Liyanage, Nilani, Pitman Lowenthal, Susan, Fisher, George A., Vinik, Aaron I.
Wydane w Oncologist (2018)

Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study

od Caplin, Martyn E., Pavel, Marianne, Phan, Alexandria T., Ćwikła, Jarosław B., Sedláčková, Eva, Thanh, Xuan-Mai Truong, Wolin, Edward M., Ruszniewski, Philippe
Wydane w Endocrine (2020)

Impact of (68)Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician’s Perspective

od Herrmann, Ken, Czernin, Johannes, Wolin, Edward M., Gupta, Pawan, Barrio, Martin, Gutierrez, Antonio, Schiepers, Christiaan, Mosessian, Sherly, Phelps, Michael E., Allen-Auerbach, Martin S.
Wydane w J Nucl Med (2014)

Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-3 Trial

od Lombard-Bohas, Catherine, Yao, James C., Hobday, Timothy, Van Cutsem, Eric, Wolin, Edward M., Panneerselvam, Ashok, Stergiopoulos, Sotirios, Shah, Manisha H., Capdevila, Jaume, Pommier, Rodney
Wydane w Pancreas (2015)

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

od Yao, James C, Chan, Jennifer A, Mita, Alain C, Kundu, Madan G, Hermosillo Reséndiz, Karina, Hu, Ke, Ravichandran, Shoba, Strosberg, Jonathan R, Wolin, Edward M
Wydane w Onco Targets Ther (2017)

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

od Buzzoni, Roberto, Carnaghi, Carlo, Strosberg, Jonathan, Fazio, Nicola, Singh, Simron, Herbst, Fabian, Ridolfi, Antonia, Pavel, Marianne E, Wolin, Edward M, Valle, Juan W, Oh, Do-Youn, Yao, James C, Pommier, Rodney
Wydane w Onco Targets Ther (2017)

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study

od Caplin, Martyn E, Pavel, Marianne, Ćwikła, Jarosław B, Phan, Alexandria T, Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M, Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Langley, Alison, Martinez, Séverine, Gomez-Panzani, Edda, Ruszniewski, Philippe
Wydane w Endocr Relat Cancer (2016)

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors

od Grenader, Tal, Pavel, Marianne E., Ruszniewski, Philippe B., Ćwikła, Jarosław B., Phan, Alexandria T., Raderer, Markus, Sedláčková, Eva, Cadiot, Guillaume, Wolin, Edward M., Capdevila, Jaume, Wall, Lucy, Rindi, Guido, Truong Thanh, Xuan-Mai, Caplin, Martyn E.
Wydane w Anticancer Drugs (2020)

Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors

od Strosberg, Jonathan R, Fisher, George A, Benson, Al B, Anthony, Lowell B, Arslan, Bulent, Gibbs, John F, Greeno, Edward, Iyer, Renuka V, Kim, Michelle K, Maples, William J, Philip, Philip A, Wolin, Edward M, Cherepanov, Dasha, Broder, Michael S
Wydane w World J Gastroenterol (2015)

Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: S...

od Yao, James C., Guthrie, Katherine A., Moran, Cesar, Strosberg, Jonathan R., Kulke, Matthew H., Chan, Jennifer A., LoConte, Noelle, McWilliams, Robert R., Wolin, Edward M., Mattar, Bassam, McDonough, Shannon, Chen, Helen, Blanke, Charles D., Hochster, Howard S.
Wydane w J Clin Oncol (2017)

Most of the Intended Management Changes After (68)Ga-DOTATATE PET/CT Are Implemented

od Calais, Jeremie, Czernin, Johannes, Eiber, Matthias, Fendler, Wolfgang P., Gartmann, Jeannine, Heaney, Anthony P., Hendifar, Andrew E., Pisegna, Joseph R., Hecht, J. Randolph, Wolin, Edward M., Slavik, Roger, Gupta, Pawan, Quon, Andrew, Schiepers, Christiaan, Allen-Auerbach, Martin S., Herrmann, Ken
Wydane w J Nucl Med (2017)

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

od Yao, James C., Shah, Manisha H., Ito, Tetsuhide, Bohas, Catherine Lombard, Wolin, Edward M., Van Cutsem, Eric, Hobday, Timothy J., Okusaka, Takuji, Capdevila, Jaume, de Vries, Elisabeth G.E., Tomassetti, Paola, Pavel, Marianne E., Hoosen, Sakina, Haas, Tomas, Lincy, Jeremie, Lebwohl, David, Öberg, Kjell
Wydane 2011